
In a new meta-analysis examining the impact of MRI-based AI models for predicting high-grade hepatocellular carcinoma, researchers noted a 10 percent decline in AUC between internal validation and external validation.

In a new meta-analysis examining the impact of MRI-based AI models for predicting high-grade hepatocellular carcinoma, researchers noted a 10 percent decline in AUC between internal validation and external validation.

In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, discusses a new study of breast arterial calcification on mammography and practical clinical implications for breast radiologists.

The updated Break Wave lithotripsy device for kidney stone treatment reportedly has ultrasound therapy probes with a 31 percent smaller footprint.

In a recent interview, Shadpour Demehri, MD, discussed new research findings suggesting a correlation between emphysema-like changes on CT and reduced bone mineral density in patients without chronic obstructive pulmonary disease (COPD).

In a study involving nearly 350 completed requests for CT scans at a pediatric hospital emergency department, researchers found that 54 percent were not appropriate according to American College of Radiology appropriateness criteria.

The combination of sustained high-gradient performance and AI capabilities with the Titanion MR may facilitate the use of imaging biomarkers that provide insight into tissue microstructure

Cystadenomas and cystadenofibromas accounted for 46 percent of benign lesions initially scored as O-RADS 4 and 5 lesions on pelvic ultrasound, according to newly published research.

Four versions of the Artis vision platform and floor configurations of the Artis icono.explore and Artis genio systems feature the Optiq AI imaging chain, which reportedly facilitates real-time analysis and data optimization.

In a new capabilities analysis of 16 CE-marked AI software platforms for CT lung cancer screening, researchers found that only 6.7 percent of supporting peer-reviewed studies were prospective and that none of the studies assessed impact on patient outcomes.

In a recent interview with Diagnostic Imaging, Leslie Lamb, MD, MSc, discussed findings from new mammography research that showed an 89.3 percent sensitivity for detecting invasive lobular carcinoma (ILC) with adjunctive AI.

The role of the radiologist is shifting, not into obsolescence but more of an architect of AI implementation and workflow orchestration in a continuously evolving health-care system.

Catch up on the top radiology content of the past week.
Recent research demonstrated that non-physician operators with brief training on the Accuro XV ultrasound system had a greater than 90 percent rate for obtaining diagnostically adequate images.

In a recent interview with Diagnostic Imaging, Soroush Adam Ramin, MD, discussed the enhanced 3D visualization and prognostic capability of Unfold AI, an MRI-based software platform that was recently added to Medicare Physician Fee Schedules for the West Coast and Mountain West regions.

Increased paraspinal intermuscular adipose tissue (IMAT) on whole-body MRI was associated with a 67 percent higher likelihood of hypertension, according to new research involving over 11,300 participants without preexisting conditions.

Emerging MRI findings from phase 3 research revealed that over 28 percent of patients with perianal fistulizing Crohn’s disease achieved combined fistula remission 24 weeks after initiating treatment with the IL-23 inhibitor guselkumab.

In a recent interview with Diagnostic Imaging, Wendie Berg, MD, PhD, shared her perspective on various aspects of the controversial breast cancer screening guidance issued by the American College of Physicians (ACP), including the use of supplemental imaging in women with dense breasts.

While previous research has demonstrated the capability of the PET/CT agent (89Zr)girentuximab for detecting clear cell renal cell carcinoma (ccRCC), a new analysis reveals a 98 percent positive predictive value (PPV) for detecting non-ccRCC renal cancers.

Patients with PRECISE 4 or 5 scores based on prostate MRI had over a 4.5-fold higher likelihood of biopsy progression in comparison to those with PRECISE 1-3 scores, according to a new multicenter study involving over 1,600 patients.

Researchers found that deep learning assessment of mammograms had an 18 percent higher accuracy than breast density in predicting future breast cancer within five years, according to a new study involving over 67,000 women.

In a recent interview with Diagnostic Imaging, Manisha Bahl, MD, MPH, SBI, offers pertinent insights on the controversial breast cancer screening guidance recently issued by the American College of Physicians (ACP).

Easily digestible formats, bullet points and summaries aside, say what you need to say in radiology reports.

In a roundup of breast imaging news and research from April 2026, we take a look back at pertinent findings with AI and digital breast tomosynthesis (DBT), breast MRI studies and breast cancer screening guidelines from the National Comprehensive Cancer Network (NCCN) and the American College of Physicians (ACP).

Catch up on the top radiology content of the past week.

In a recent interview, Stamatia Destounis, MD, offered her perspective about the recent American College of Physicians (ACP) guidance on breast cancer screening and concerns over recommendations in women with dense breasts and biennial versus annual mammography screening.

The benefits of photon-counting CT via ultra-high spatial resolution, reduced blooming artifacts and high temporal resolution allow characterization with confidence in coronary stent assessment.


Called a “star physician” by President Trump, Nicole Saphier, MD, a board-certified breast radiologist and associate professor at Weill Cornell Medical College, “is a tireless advocate for women’s health,” according to American College of Radiology (ACR) CEO Dana H. Smetherman, MD.

In an independent test set, a radiomic AI model demonstrated an 82 percent AUC for detecting pancreatic ductal adenocarcinoma on computed tomography (CT) scans at a median of nearly 16 months prior to clinical diagnosis.

In a recent interview, Matthew Hulse, a certified nuclear medicine technologist, discussed the evolution of amyloid PET imaging in managing patients with Alzheimer’s disease, the impact on PET imaging volume and the emergence of quantification platforms for monitoring treatment efficacy.